Skip to content
Project discovery

Discover projects through expert evaluations.

Buy, sell or wait? See what experts think about companies and crypto projects. Join Orbitrum for free and explore available evaluations before you invest.

Browse public profiles and previews for free. Evaluation availability and full content access depend on the profile and expert offer.

Search projects by name or sector
4357 projects
Display
Eli Lilly
92.9
UndisclosedUndisclosed3 evals
Hoya Corp
91.0
UndisclosedUndisclosed1 evals
Hoya Cor
90.3
UndisclosedUndisclosed1 evals
Veeva Systems
89.9
UndisclosedUndisclosed1 evals
Boston Scientific
89.8
UndisclosedUndisclosed1 evals
arGEN X BV
89.7
UndisclosedUndisclosed1 evals
IDEXX Laboratories
89.5
UndisclosedUndisclosed1 evals
Otsuka
Otsukaweb2
89.5
UndisclosedUndisclosed1 evals
Daiichi Sankyo ADR
89.4
UndisclosedUndisclosed1 evals
Resmed
Resmedweb2
89.3
UndisclosedUndisclosed1 evals
Roche Holding
89.3
UndisclosedUndisclosed3 evals
McKesson
89.2
UndisclosedUndisclosed1 evals
Shenzhen Mindray Bio-Medical
89.0
UndisclosedUndisclosed1 evals
Takeda Pharmaceutical Co
89.0
UndisclosedUndisclosed1 evals
Terumo
Terumoweb2
89.0
UndisclosedUndisclosed1 evals
Daiichi Sankyo
88.8
UndisclosedUndisclosed1 evals
BeOne Medicines
88.8
UndisclosedUndisclosed1 evals
Novartis DRC
88.8
UndisclosedUndisclosed2 evals
Insmed
Insmedweb2
88.6
UndisclosedUndisclosed1 evals
Edwards Lifesciences
88.5
UndisclosedUndisclosed1 evals
United Therapeutics
88.5
UndisclosedUndisclosed1 evals
Tenet Healthcare
88.4
UndisclosedUndisclosed1 evals
Genmab
Genmabweb2
88.4
UndisclosedUndisclosed1 evals
Gilead Sciences
88.3
UndisclosedUndisclosed2 evals
WuXi Biologics
88.3
UndisclosedUndisclosed1 evals
AstraZeneca
88.2
UndisclosedUndisclosed2 evals
Sanofi
Sanofiweb2
88.2
UndisclosedUndisclosed2 evals
Intuitive Surgical
88.0
UndisclosedUndisclosed2 evals
Ascendis Pharma AS
88.0
UndisclosedUndisclosed1 evals
Samsung Biologics
87.8
UndisclosedUndisclosed1 evals
GSK plc DRC
87.7
UndisclosedUndisclosed1 evals
Royalty Pharma
87.7
UndisclosedUndisclosed1 evals
Straumann Holding
87.7
UndisclosedUndisclosed1 evals
Innovent Biologics
87.6
UndisclosedUndisclosed1 evals
Sichuan Biokin Pharmaceutical
87.6
UndisclosedUndisclosed1 evals
Pro Medicus Ltd
87.5
UndisclosedUndisclosed1 evals
Chugai Pharma ADR
87.4
UndisclosedUndisclosed2 evals
AbbVie
AbbVieweb2
87.3
UndisclosedUndisclosed2 evals
Jiangsu Hengrui
87.2
UndisclosedUndisclosed1 evals
Cardinal Health
87.1
UndisclosedUndisclosed1 evals
Jiangsu Hengrui Pharmaceuticals
87.1
UndisclosedUndisclosed1 evals
Waters
Watersweb2
87.1
UndisclosedUndisclosed1 evals
West Pharmaceutical Services
87.0
UndisclosedUndisclosed1 evals
Danaher
87.0
UndisclosedUndisclosed1 evals
STERIS
STERISweb2
86.9
UndisclosedUndisclosed1 evals
Swedish Orphan Biovitrum AB
86.9
UndisclosedUndisclosed1 evals
Regeneron Pharma
86.8
UndisclosedUndisclosed1 evals
Krka
Krkaweb2
86.7
UndisclosedUndisclosed1 evals
Sartorius Stedim
86.6
UndisclosedUndisclosed1 evals
Penumbra Inc
86.6
UndisclosedUndisclosed1 evals
Sonova Holding
86.6
UndisclosedUndisclosed1 evals
WuXi AppTec
86.5
UndisclosedUndisclosed1 evals
Fisher Paykel Healthcare
86.4
UndisclosedUndisclosed1 evals
Johnson Johnson
86.4
UndisclosedUndisclosed3 evals
Lonza Group
86.3
UndisclosedUndisclosed1 evals
Stryker
86.3
UndisclosedUndisclosed1 evals
Novartis
86.2
UndisclosedUndisclosed2 evals
Biomerieux
86.1
UndisclosedUndisclosed1 evals
Recordati
86.1
UndisclosedUndisclosed1 evals
HCA Healthcare
86.0
UndisclosedUndisclosed2 evals
Thermo Fisher Scientific
86.0
UndisclosedUndisclosed2 evals
Halozyme
86.0
UndisclosedUndisclosed1 evals
Takeda Pharma ADR
86.0
UndisclosedUndisclosed2 evals
Alcon
Alconweb2
85.9
UndisclosedUndisclosed1 evals
Biogen
Biogenweb2
85.9
UndisclosedUndisclosed1 evals
Swedish Orphan Biovitrum AB ADR
85.9
UndisclosedUndisclosed1 evals
UCB
UCBweb2
85.9
UndisclosedUndisclosed1 evals
Bristol Myers Squibb
85.8
UndisclosedUndisclosed1 evals
Labcorp Holdings
85.8
UndisclosedUndisclosed1 evals
Sanofi DRC
85.8
UndisclosedUndisclosed1 evals
Exelixis
85.7
UndisclosedUndisclosed1 evals
Biocytogen Pharmaceuticals Beijing
85.6
UndisclosedUndisclosed1 evals
Medline
85.5
UndisclosedUndisclosed1 evals
Revolution Med
85.5
UndisclosedUndisclosed1 evals
Novo Nordisk AS
85.5
UndisclosedUndisclosed2 evals
IQVIA Holdings
85.3
UndisclosedUndisclosed1 evals
Dexcom
Dexcomweb2
85.3
UndisclosedUndisclosed1 evals
Protagonist Therapeutics
85.3
UndisclosedUndisclosed1 evals
Divi's Labs
85.1
UndisclosedUndisclosed1 evals
Madrigal Pharma
85.1
UndisclosedUndisclosed1 evals
Novartis AG DRC SA
85.1
UndisclosedUndisclosed2 evals
CSPC Pharma
85.0
UndisclosedUndisclosed1 evals
GE Healthcare Tech
85.0
UndisclosedUndisclosed1 evals
Sun Pharma
85.0
UndisclosedUndisclosed1 evals
Sonova Holding AG
84.9
UndisclosedUndisclosed1 evals
Illumina
84.8
UndisclosedUndisclosed1 evals
Ipsen
Ipsenweb2
84.8
UndisclosedUndisclosed1 evals
Alnylam
84.8
UndisclosedUndisclosed1 evals
Terumo ADR
84.7
UndisclosedUndisclosed1 evals
Jazz Pharmaceuticals
84.6
UndisclosedUndisclosed1 evals
EssilorLuxottica
84.5
UndisclosedUndisclosed2 evals
Abbott Laboratories
84.5
UndisclosedUndisclosed3 evals
BioNTech SE
84.5
UndisclosedUndisclosed1 evals
Alteogen
84.4
UndisclosedUndisclosed1 evals
Chugai Pharma
84.4
UndisclosedUndisclosed2 evals
Demant ADR
84.3
UndisclosedUndisclosed1 evals
Agilent Technologies
84.2
UndisclosedUndisclosed1 evals
Elevance Health
84.1
UndisclosedUndisclosed1 evals
IHH Healthcare
84.1
UndisclosedUndisclosed1 evals
Sichuan Kelun Biotech
84.1
UndisclosedUndisclosed1 evals
...

Experts behind these project evaluations

Thierry Beaucamp
Orbitrum.io Co-Founder - CTO & Head of Products | Kudora Ecosystem Lead
View
Cyril CESAR
Cyril CESARVerified
Strategic & Business Operation
View
Ethan AI
Ethan AIVerified
Web2 & Web3 Advisor
View
For experts

Publish your project evaluations and research.

Share your assessments, explain the reasoning behind your scores and help investors understand the projects you research.

Apply to contribute your expertise.

Applications are reviewed by the Orbitrum team. Relevant experience and a verifiable track record help us assess each application.

Invite-only. Rolling admission.

Orbitrum Academy

Learn how to examine project research

Use source-based guides to structure due diligence, assess technical and commercial evidence, and interpret expert reasoning.

Explore Orbitrum Academy

Find the original documents

Use Orbitrum Resources to locate provider documentation, company filings and regulatory records.

Explore research resources